Ryan Melkonian Progenics Pharmaceuticals Inc

As of September 9, 2019


What is Ryan Melkonian's Net Worth?

The current estimated net worth of Progenics Pharmaceuticals Inc's Ryan Melkonian is estimated to be about $9.22M . Ryan Melkonian owns about 1,950,000 units of Progenics Pharmaceuticals Inc common stock. Recently at Progenics Pharmaceuticals Inc, Ryan Melkonian has sold an estimated value of $0 worth.

What is Ryan Melkonian's Past Insider Trading?

Ryan Melkonian's largest purchase order was 65,000 units , worth over $307.19K on September 9, 2019. In total, Ryan Melkonian has made about 1 transaction recently at Progenics Pharmaceuticals Inc. Ryan Melkonian usually trades in September, with the busiest year in 2019.

LTE Partners LLC, Melkonian Capital Management LLC, LTE Management LLC, Ryan Melkonian

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ryan Melkonian's' Mailing Address?

  • Mailing address is C/o Melkonian Capital Management, Llc 450 West 31st Street, 12th Fl New York NY 10001 NY

What are Progenics Pharmaceuticals Inc's Past Insider Trades?

Progenics Pharmaceuticals Inc's most recent insider trade came on September 11, 2019 by Velan Capital Lp, Altiva Management Inc and Balaji Venkataraman who bought 72,023 units worth $359.73K . In the last 4 years, insiders at Progenics Pharmaceuticals Inc have sold an estimated value of $18.27M and bought an estimated value of $4.31M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Bradley Campbell, Director,  Bryce Tenbarge, SVP,  and David A Scheinberg .

PROGENICS PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1